Evidence map›Paper›PMID 38861304›Full record

ArticleFuture oncology (London, England)2024

Dysregulation of exosomal miRNAs and their related genes in head and neck cancer patients.

Muhammad Rizwan, Ishrat Mahjabeen, Nida Sarosh Ashraf, Maryam Arshad, Muhammad Shahbaz Haris, Mahmood Akhtar Kayani

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future oncology (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Observational
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Muhammad RizwanCancer Genetics & Epigenetics research group, Department of Biosciences, COMSATS University, Park Road Islamabad, Pakistan.
Ishrat MahjabeenCancer Genetics & Epigenetics research group, Department of Biosciences, COMSATS University, Park Road Islamabad, Pakistan.ORCID 0000-0002-6392-672X
Nida Sarosh AshrafCancer Genetics & Epigenetics research group, Department of Biosciences, COMSATS University, Park Road Islamabad, Pakistan.
Maryam ArshadCancer Genetics & Epigenetics research group, Department of Biosciences, COMSATS University, Park Road Islamabad, Pakistan.
Muhammad Shahbaz HarisCancer Genetics & Epigenetics research group, Department of Biosciences, COMSATS University, Park Road Islamabad, Pakistan.
Mahmood Akhtar KayaniCancer Genetics & Epigenetics research group, Department of Biosciences, COMSATS University, Park Road Islamabad, Pakistan.ORCID 0000-0001-9886-180X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomarkers, TumorExosomesGene Expression Regulation, NeoplasticHead and Neck NeoplasmsMicroRNAsAdultAgedCase-Control StudiesFemaleHumansKaplan-Meier EstimateMaleMiddle AgedPrognosisROC CurveSmad2 ProteinBiomarkers, TumorMicroRNAsMIRN19A microRNA, humanSmad2 ProteinSMAD2 protein, humanSmad4 ProteinSMAD4 protein, humandiagnostic markersexosomal microRNAexosomesHNCmiR-17-92 polycistronic clustermiR-19amiR-19bquantitative PCRSMAD2SMAD4

Identifiers

PMID38861304
PMCPMC11441060

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.